Findings from an Organizational Context Survey to Inform the Implementation of a Collaborative Care Study for Co-occurring Disorders.
Co-occurring disorders
Collaborative care
Consolidated Framework for Implementation Research (CFIR)
Contextual factors
Organizational readiness
Pre-implementation
Journal
The journal of behavioral health services & research
ISSN: 1556-3308
Titre abrégé: J Behav Health Serv Res
Pays: United States
ID NLM: 9803531
Informations de publication
Date de publication:
03 Aug 2023
03 Aug 2023
Historique:
accepted:
14
07
2023
medline:
4
8
2023
pubmed:
4
8
2023
entrez:
3
8
2023
Statut:
aheadofprint
Résumé
Primary care is an opportune setting to deliver treatments for co-occurring substance use and mental health disorders; however, treatment delivery can be challenging due multi-level implementation barriers. Documenting organizational context can provide insight into implementation barriers and the adaptation of new processes into usual care workflows. This study surveyed primary care and behavioral health staff from 13 clinics implementing a collaborative care intervention for opioid use disorders co-occurring with PTSD and/or depression as part of a multisite randomized controlled trial. A total of 323 completed an online survey for a 60% response rate. The Consolidated Framework for Implementation Research guided this assessment of multi-level factors that influence implementation. Most areas for improvement focused on inner setting (organizational level) constructs whereas individual-level constructs tended to be strengths. This work addresses a research gap regarding how organizational analyses can be used prior to implementation and provides practical implications for researchers and clinic leaders.
Identifiants
pubmed: 37537428
doi: 10.1007/s11414-023-09851-6
pii: 10.1007/s11414-023-09851-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIMH NIH HHS
ID : UF1 MH121954
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Drug Overdose Deaths Remain High. Atlanta, GA: Centers for Disease Control and Prevention, 2022. Available at https://www.cdc.gov/drugoverdose/deaths/index.html . Accessed 10 September, 2022.
Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 2007; 64(5):566-576. https://doi.org/10.1001/archpsyc.64.5.566 .
doi: 10.1001/archpsyc.64.5.566
pubmed: 17485608
Han B, Compton WM, Blanco C, et al. Prevalence, treatment, and unmet treatment needs of US adults with mental health and substance use disorders. Health Affairs 2017; 36(10):1739-1747. https://doi.org/10.1377/hlthaff.2017.0584 .
doi: 10.1377/hlthaff.2017.0584
pubmed: 28971918
The Economic Impact of Illicit Drug Use on American Society. Washington, D.C.: U.S. Department of Justice, National Drug Intelligence Center, 2011. Available at https://www.justice.gov/archive/ndic/ndic-moved.html . Accessed 8 December, 2022.
Brown RF, Tennant CC, Sharrock M, et al. Relationship between stress and relapse in multiple sclerosis: Part I important features. Multiple Sclerosis 2006; 12(4):453-464. https://doi.org/10.1191/1352458506ms1295oa .
doi: 10.1191/1352458506ms1295oa
pubmed: 16900759
Dore G, Mills K, Murray R, et al. Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders. Drug and Alcohol Review 2012; 31(3):294-302. https://doi.org/10.1111/j.1465-3362.2011.00314.x .
doi: 10.1111/j.1465-3362.2011.00314.x
pubmed: 21521385
Meier A, Lambert-Harris C, McGovern MP, et al. Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity. The American Journal of Drug and Alcohol Abuse 2014; 40(4):304-311. https://doi.org/10.3109/00952990.2014.910519 .
doi: 10.3109/00952990.2014.910519
pubmed: 24809229
pmcid: 4883674
Mills KL, Teesson M, Ross J, et al. Trauma, PTSD, and substance use disorders: Findings from the Australian national survey of mental health and well-being. The American Journal of Psychiatry 2006; 163(4):652-658.
doi: 10.1176/ajp.2006.163.4.652
pubmed: 16585440
Tormohlen KN, Mojtabai R, Seiwell A, et al. Co-occurring opioid use and depressive disorders: Patient characteristics and co-occurring health conditions. Journal of Dual Diagnosis 2021; 17(4):296-303. https://doi.org/10.1080/15504263.2021.1979349 .
doi: 10.1080/15504263.2021.1979349
pubmed: 34581663
pmcid: 10294295
Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 2004; 61(8):807-816. https://doi.org/10.1001/archpsyc.61.8.807 .
doi: 10.1001/archpsyc.61.8.807
pubmed: 15289279
Osilla KC, Dopp AR, Watkins KE, et al. Collaboration leading to addiction treatment and recovery from other stresses (CLARO): Process of adapting collaborative care for co-occurring opioid use and mental disorders. Addiction Science and Clinical Practice 2022; 17(1):25. https://doi.org/10.1186/s13722-022-00302-9 .
doi: 10.1186/s13722-022-00302-9
pubmed: 35395811
pmcid: 8991671
Pilowsky DJ, Wu LT. Screening for alcohol and drug use disorders among adults in primary care: A review. Substance Abuse and Rehabilitation 2012; 3(1):25-34. https://doi.org/10.2147/SAR.S30057 .
doi: 10.2147/SAR.S30057
pubmed: 22553426
pmcid: 3339489
Meredith LS, Eisenman DP, Han B, et al. Impact of collaborative care for underserved patients with PTSD in primary care: A randomized controlled trial. Journal of General Internal Medicine 2016; 31(5):509-517. https://doi.org/10.1007/s11606-016-3588-3 .
doi: 10.1007/s11606-016-3588-3
pubmed: 26850413
pmcid: 4835392
Watkins KE, Ober AJ, Lamp K, et al. Collaborative care for opioid and alcohol use disorders in primary care: The SUMMIT randomized clinical trial. JAMA Internal Medicine 2017; 177(10):1480-1488. https://doi.org/10.1001/jamainternmed.2017.3947 .
doi: 10.1001/jamainternmed.2017.3947
pubmed: 28846769
pmcid: 5710213
Meredith LS, Komaromy MS, Cefalu M, et al. Design of CLARO (collaboration leading to addiction treatment and recovery from other stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder. Contemporary Clinical Trials 2021; 104:106354. https://doi.org/10.1016/j.cct.2021.106354 .
doi: 10.1016/j.cct.2021.106354
pubmed: 33713840
pmcid: 8432760
Brunette MF, Asher D, Whitley R, et al. Implementation of integrated dual disorders treatment: A qualitative analysis of facilitators and barriers. Psychiatric Services 2008; 59(9):989-995. https://doi.org/10.1176/ps.2008.59.9.989 .
doi: 10.1176/ps.2008.59.9.989
pubmed: 18757591
Waltz TJ, Powell BJ, Fernandez ME, et al. Choosing implementation strategies to address contextual barriers: Diversity in recommendations and future directions. Implementation Science 2019; 14(1):42. https://doi.org/10.1186/s13012-019-0892-4 .
doi: 10.1186/s13012-019-0892-4
pubmed: 31036028
pmcid: 6489173
Fokuo JK, McCuistian CL, Masson CL, et al. Pre-implementation assessment of tobacco cessation interventions in substance use disorder residential programs in California. Substance Use and Misuse 2022; 57(9):1345-1355. https://doi.org/10.1080/10826084.2022.2079139 .
doi: 10.1080/10826084.2022.2079139
pubmed: 35621319
Kirk MA, Kelley C, Yankey N, et al. A systematic review of the use of the consolidated framework for implementation research. Implementation Science 2016; 11:72. https://doi.org/10.1186/s13012-016-0437-z .
doi: 10.1186/s13012-016-0437-z
pubmed: 27189233
pmcid: 4869309
Fernandez ME, Walker TJ, Weiner BJ, et al. Developing measures to assess constructs from the inner setting domain of the consolidated framework for implementation research. Implementation Science 2018; 13. https://doi.org/10.1186/s13012-018-0736-7 .
Weir A, Presseau J, Kitto S, et al. Strategies for facilitating the delivery of cluster randomized trials in hospitals: A study informed by the CFIR-ERIC matching tool. Clinical Trials 2021; 18(4):398-407. https://doi.org/10.1177/17407745211001504 .
doi: 10.1177/17407745211001504
pubmed: 33863242
Damschroder LJ, Reardon CM, Opra Widerquist MA, et al. Conceptualizing outcomes for use with the consolidated framework for implementation research (CFIR): The CFIR outcomes addendum. Implementation Science 2022; 17(1):7. https://doi.org/10.1186/s13012-021-01181-5 .
doi: 10.1186/s13012-021-01181-5
pubmed: 35065675
pmcid: 8783408
Kononowech J, Hagedorn H, Hall C, et al. Mapping the organizational readiness to change assessment to the consolidated framework for implementation research. Implementation Science Communications 2021; 2(1):19. https://doi.org/10.1186/s43058-021-00121-0 .
doi: 10.1186/s43058-021-00121-0
pubmed: 33581728
pmcid: 7881456
Anseel F, Beatty AS, Shen W, et al. How are we doing after 30 years? A meta-analytic review of the antecedents and outcomes of feedback-seeking behavior. Journal of Management 2015; 41(1):318-348. https://doi.org/10.1177/0149206313484521 .
doi: 10.1177/0149206313484521
Baruch Y, Ramalho N. Communalities and distinctions in the measurement of organizational performance and effectiveness across for-profit and nonprofit sectors. Nonprofit and Voluntary Sector Quarterly 2006; 35(1):39-65. https://doi.org/10.1177/0899764005282468 .
doi: 10.1177/0899764005282468
Kegler MC, Liang S, Weiner BJ, et al. Measuring constructs of the consolidated framework for implementation research in the context of increasing colorectal cancer screening in federally qualified health center. Health Services Research 2018; 53(6):4178-4203. https://doi.org/10.1111/1475-6773.13035 .
doi: 10.1111/1475-6773.13035
pubmed: 30260471
pmcid: 6232399
Yang LH, Grivel MM, Anderson B, et al. A new brief opioid stigma scale to assess perceived public attitudes and internalized stigma: Evidence for construct validity. Journal of Substance Abuse Treatment 2019; 99:44-51. https://doi.org/10.1016/j.jsat.2019.01.005 .
doi: 10.1016/j.jsat.2019.01.005
pubmed: 30797393
pmcid: 6716158
Damschroder LJ, Reardon CM, AuYoung M, et al. Implementation findings from a hybrid III implementation-effectiveness trial of the Diabetes Prevention Program (DPP) in the Veterans Health Administration (VHA). Implementation Science 2017; 12(1):94. https://doi.org/10.1186/s13012-017-0619-3 .
doi: 10.1186/s13012-017-0619-3
pubmed: 28747191
pmcid: 5530572